The t(2; 5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin

Blood

Volumn 87, Issue 8, 1996, Pages 3437-3441

  DeCoteau, John F ^b   Butmarc, Janet R ^b   Kinney, Marsha C ^b   Kadin, Marshall E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC CARCINOMA; ARTICLE; CHROMOSOME 2; CHROMOSOME 5; CHROMOSOME TRANSLOCATION; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD30; ANTIGENS, NEOPLASM; BASE SEQUENCE; CHILD; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 5; DIAGNOSIS, DIFFERENTIAL; HODGKIN DISEASE; HUMANS; HYPERPLASIA; LYMPH NODES; LYMPHOMA, LARGE-CELL; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISORDERS; MOLECULAR SEQUENCE DATA; MYCOSIS FUNGOIDES; PROGNOSIS; RNA, NEOPLASM; SKIN DISEASES; SKIN NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0029918674     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.8.3437.bloodjournal8783437     Document Type: Review

References (24)

1. Beljaards RC, Kaudewitz P, Bert E, Gianotti R, Neuman C, Rosso R, Paulli M, Meijer CJ, Willemze R: Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favourable prognosis. Cancer 71:2097, 1993
2. Willemze R, Beljaards RC: Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 28:973, 1993
3. Beljaards RC, Willemze R: The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol 126:596, 1992
4. Paulli M, Berti E, Rosso R, Boveri E, Kindl S, Klersy C, Lazzarino M, Borroni G, Menestrina F, Santucci M, Gambini C, Vassallo G, Magrini U, Sterry W, Burg G, Geerts ML, Meijer CJLM, Willemze R, Feller AC, Muller-Hermelink HK, Kadin ME: CD30/ Ki-1-positive lymphoprohferative disorders of the skin - Clinicopathologic correlation and statistical analysis of 86 cases: A multicenter study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 13:1343, 1995
5. De Bruin PC, Beljaards RC, Van Heerde P, Van Der Valk P, Noorduyn LA, Van Krieken JHJM, Kluin-Nelemans JC, Willemze R, Meijer CJLM: Differences in clinical behavior and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null phenotype. Histopathology 23:127, 1993
6. Kadin ME: Primary Ki-1 positive anaplastic large cell lymphoma: A distinct clinicopathologic entity. Ann Oncol 5:S25, 1994 (suppl 1)
7. Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmermann M, Yakisan E, Dopfer R, Bucsky P, Mann G, Gadner H: Successful treatment strategy for Ki-1 anaplastic large cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899, 1994
8. + lymphomas, from American and Asian patients. Am J Pathol 146:323, 1995
9. Downing JR, Shurtleff SA, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT, Weisenberger DD, Kossakowska AE, Thorner P, Lorenzana A, Ladanyi M, Morris S: Molecular detection of the (2; 5) translocation of non-Hodgkin's lymphoma by reverse transcriptase polymerase chain reaction. Blood 85:3416, 1995
10. Morris S, Kirstein M, Valentine M, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1282, 1994
11. + anaplastic large cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 86:2321, 1995
12. Shiota M, Takenaga M, Satoh H, Ichinohasama R, Abe M, Nakano M, Yamamoto T, Mori S: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648, 1994
13. Peters K, Knoll JH, Kadin ME: Cytogenetic findings in regressing skin lesions of lymphomatoid papulosis. Cancer Genet Cytogenet 80:13, 1995
14. + anaplastic large cell lymphoma: Establishment of a new tumor cell line transplantable to SCID mice. Blood 76:345a, 1990 (abstr)
15. + T-cell lymphoma. Am J Surg Pathol 17:859, 1993
16. Chott A, Kaserer K, Augustin I, Veseley M, Heinz R, Oehlinger W, Hanak H, Radaskiewicz T: Ki-1-positive large cell lymphoma: A clinicopathologic study of 41 cases. Am J Surg Pathol 14:439, 1990
17. Weiss LM, Warnke RA, Sklar J, Cleary M: Molecular analysis of the t(14; 18) translocation in malignant lymphomas. N Engl J Med 317:1185, 1987
18. Medeiros LJ, Van Krieken JH, Jaffe ES, Raffeld M: Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood 76:2086, 1990
19. Pelicci P-G, Knowles DM, Magrath IT, Dalla-Favera R: Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 83:2984, 1986
20. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM: Nucleophosmin gene rearrangements in Ki-1-positive lymphomas. Cancer Res 54:2873, 1994
21. Orscheschek K, Merz H, Hall J, Binder T, Bartels H, Feller AC: Large cell anaplastic specific translocation t(2;5)(p23;q35) in Hodgkin's disease: Indication of a common pathogenesis? Lancet 345:87, 1995
22. Volkenandt M, Bertino JR, Shenoy BV, Koch OM, Kadin ME: Molecular evidence for a clonal relationship between lymphomatoid papulosis and Ki-1 positive large cell anaplastic lymphoma. J Dermatol Sci 6:121, 1993
23. Vonderheid EC, Sajjadian A, Kadin ME: Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol (in press) 1995
24. Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, Mori N, Fujimoto J, Miyauchi J, Mikata A, Nanba K, Takami T, Yamabe H, Takano Y, Izumo T, Nagatani T, Mohri N, Nasu K, Satoh H, Katano H, Fujimoto J, Yamamoto T, Mori S: Anaplastic large cell lymphomas expressing the novel chimeric protein p80 NPM/ALK: A distinct clinicopathologic entity. Blood 86:1954, 1995